Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-27

Clinical Trial Update: 31P-MRS and Huntington Disease [NA]

View source ↗

Summary

A completed clinical trial investigated phosphorus-31 magnetic resonance spectroscopy (31P-MRS) in individuals with Huntington's disease, sponsored by INSERM in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Huntington Disease | NA | Status: COMPLETED